Latest filing published 31 Mar 2026 for LOEWS CORP. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Ann e. Berman across 3 companies, led by Loews Corp, Immuneering Corp and Cantel Medical Corp. Over a trading history stretching from 1 June 2021 to 31 March 2026, the count stands at 34 filings.
Both buying and selling appear: 3 purchases worth €193k, against 2 sales worth €312k. On balance, insiders were net sellers of €120k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 share grants and 23 option exercises. 2026 to date brings no purchases and 1 sale.
In size, the median ticket on the buying side is €44k. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 31 March 2026, reports a share grant in Loews Corp. The most recent open-market purchase was published on 19 March 2024, 943 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 34 declarations